As of 2:20 p.m., shares traded at 20,000 won ($14.40), double its 10,000 won offering price. The stock opened at 8,500 won and fell as low as 8,200 won. It later climbed to an intraday high of 28,750 won, 187.5 percent above the IPO price.
The sharp reversal made the company one of the most actively traded stocks on the KOSDAQ. Trading volume had reached about 75 million shares, with turnover of roughly 1.43 trillion won by around 2:20 p.m.
The strong first-day performance contrasted with relatively weak demand during the offering process. Institutional bookbuilding recorded a competition ratio of 63.41 to 1, while retail subscriptions drew a ratio of about 2.9 to 1. The IPO was priced at 10,000 won, below the initially proposed range of 13,000 won to 16,000 won.
The company develops wearable devices that allow users to measure health indicators through a ring worn on the finger. Its flagship product, Cardio Tracker (CART), is an artificial intelligence-powered cuffless blood pressure monitor designed to continuously track blood pressure without a conventional arm cuff.
It was founded in 2015. It reported about 7.9 billion won in revenue and a 14.7 billion won operating loss last year, putting the focus on whether the company can translate its technology into sustained sales growth and improved profitability after the strong debut.
AJP Takeaways
- Sky Labs shares traded at 20,000 won as of 2:20 p.m. on Sept. 4, 2026, double the South Korean digital healthcare company’s 10,000 won initial public offering price on its KOSDAQ debut.
- Sky Labs shares swung from an intraday low of 8,200 won to a high of 28,750 won on Sept. 4, 2026, with the peak representing a 187.5 percent gain from the IPO price.
- Sky Labs drew relatively weak demand before listing, with institutional bookbuilding at 63.41 to 1 and retail subscriptions at about 2.9 to 1, while the final IPO price was set below the initially proposed range of 13,000 won to 16,000 won.
Copyright ⓒ Aju Press All rights reserved.
